Skip to main content
SpringerLink
Log in

Significant association of different preS mutations with hepatitis B-related cirrhosis or hepatocellular carcinoma

  • Original Article—Liver, Pancreas, and Biliary Tract
  • Published:
Journal of Gastroenterology Aims and scope Submit manuscript

Abstract

Background

The associations of nucleotide substitution mutations in the preS region of hepatitis B virus (HBV) with hepatocellular carcinoma (HCC) and cirrhosis remain unknown. We aimed to determine the associations of preS mutations with HCC or cirrhosis.

Methods

HBV from 603 asymptomatic hepatitis B surface antigen carriers (ASCs), 219 chronic hepatitis B (CHB) patients, 119 cirrhosis patients, and 231 HCC patients were genotyped and sequenced in the preS region. Nucleotides with the highest frequencies in HBV from the hepatitis B e antigen (HBeAg)-positive ASCs were treated as “wild-type” nucleotides. Twenty-one preS1 mutations and 14 preS2 mutations were evaluated. Multivariate regression analyses were applied to determine factors independently associated with cirrhosis or HCC.

Results

Most (85.7%) preS2 mutations were associated with CHB compared with ASCs, whereas most preS1 mutations were associated with HCC compared with the cirrhosis patients or CHB patients. Compared with the CHB patients, 81.0% preS1 mutations in genotype C were inversely associated with cirrhosis. Multivariate regression analyses showed that C2964A, C3116T, and C7A were novel factors associated with HCC compared with those without HCC, whereas A2964C and T3116C were independently associated with cirrhosis compared with ASCs and the CHB patients. Combined preS1 mutations had specificities greater than 95%, while C3116T and C7A had moderate sensitivities and specificities, for HCC.

Conclusions

C2964A, C3116T, and C7A are novel markers independently associated with an increased risk of HCC, while A2964C and T3116C are novel markers independently associated with an increased risk of cirrhosis. Combined preS1 mutations are specific for HCC.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

Abbreviations

ALT:

Alanine aminotransferase

AOR:

Adjusted odds ratio

ASC:

Asymptomatic hepatitis B surface antigen carrier

CHB:

Chronic hepatitis B

HBV:

Hepatitis B virus

HBeAg:

Hepatitis B e antigen

HBsAg:

Hepatitis B surface antigen

HCC:

Hepatocellular carcinoma

LC:

Liver cirrhosis

References

  1. Nguyen VT, Law MG, Dore GJ. Hepatitis B-related hepatocellular carcinoma: epidemiological characteristics and disease burden. J Viral Hepat. 2009;16:453–63.

    Article  CAS  PubMed  Google Scholar 

  2. Kay A, Zoulim F. Hepatitis B virus genetic variability and evolution. Virus Res. 2007;127:164–76.

    Article  CAS  PubMed  Google Scholar 

  3. Schaefer S. Hepatitis B virus: significance of genotypes. J Viral Hepat. 2005;12:111–24.

    Article  CAS  PubMed  Google Scholar 

  4. Cao GW. Clinical relevance and public health significance of hepatitis B virus genomic variations. World J Gastroenterol. 2009;15:5761–9.

    Article  CAS  PubMed  Google Scholar 

  5. Sugauchi F, Ohno T, Orito E, Sakugawa H, Ichida T, Komatsu M, et al. Influence of hepatitis B virus genotypes on the development of preS deletions and advanced liver disease. J Med Virol. 2003;70:537–44.

    Article  CAS  PubMed  Google Scholar 

  6. Gao ZY, Li T, Wang J, Du JM, Li YJ, Li J, et al. Mutations in preS genes of genotype C hepatitis B virus in patients with chronic hepatitis B and hepatocellular carcinoma. J Gastroenterol. 2007;42:761–8.

    Article  CAS  PubMed  Google Scholar 

  7. Mu SC, Lin YM, Jow GM, Chen BF. Occult hepatitis B virus infection in hepatitis B vaccinated children in Taiwan. J Hepatol. 2009;50:264–72.

    Article  CAS  PubMed  Google Scholar 

  8. Chen CH, Hung CH, Lee CM, Hu TH, Wang JH, Wang JC, et al. Pre-S deletion and complex mutations of hepatitis B virus related to advanced liver disease in HBeAg-negative patients. Gastroenterology. 2007;133:1466–74.

    Article  CAS  PubMed  Google Scholar 

  9. Fang ZL, Sabin CA, Dong BQ, Wei SC, Chen QY, Fang KX, et al. Hepatitis B virus pre-S deletion mutations are a risk factor for hepatocellular carcinoma: a matched nested case-control study. J Gen Virol. 2008;89(Pt 11):2882–90.

    Article  CAS  PubMed  Google Scholar 

  10. Chen BF, Liu CJ, Jow GM, Chen PJ, Kao JH, Chen DS. High prevalence and mapping of pre-S deletion in hepatitis B virus carriers with progressive liver diseases. Gastroenterology. 2006;130:1153–68.

    Article  CAS  PubMed  Google Scholar 

  11. Choi MS, Kim DY, Lee DH, Lee JH, Koh KC, Paik SW, et al. Clinical significance of pre-S mutations in patients with genotype C hepatitis B virus infection. J Viral Hepat. 2007;14:161–8.

    Article  CAS  PubMed  Google Scholar 

  12. Liu S, Zhang H, Gu C, Yin J, He Y, Xie J, et al. Associations between hepatitis B virus mutations and the risk of hepatocellular carcinoma: a meta-analysis. J Natl Cancer Inst. 2009;101:1066–82.

    Article  CAS  PubMed  Google Scholar 

  13. Yin J, Zhang H, He Y, Xie J, Liu L, Chang W, et al. Distribution and hepatocellular carcinoma-related viral properties of hepatitis B virus genotypes in Mainland China: a community-based study. Cancer Epidemiol Biomarkers Prev. 2010;19:777–86.

    Article  CAS  PubMed  Google Scholar 

  14. Lok AS, McMahon BJ. Chronic hepatitis B. Hepatology. 2007;45:507–39.

    Article  CAS  PubMed  Google Scholar 

  15. Zhang HW, Yin JH, Li YT, Li CZ, Ren H, Gu CY, et al. Risk factors for acute hepatitis B and its progression to chronic hepatitis in Shanghai, China. Gut. 2008;57:1713–20.

    Article  CAS  PubMed  Google Scholar 

  16. Yin J, Zhang H, Li C, Gao C, He Y, Zhai Y, et al. Role of hepatitis B virus genotype mixture, subgenotypes C2 and B2 on hepatocellular carcinoma: compared with chronic hepatitis B and asymptomatic carrier state in the same area. Carcinogenesis. 2008;29:1685–91.

    Article  CAS  PubMed  Google Scholar 

  17. Chen J, Yin J, Tan X, Zhang H, Chen B, Chang W, et al. Improved multiplex-PCR to identify hepatitis B virus genotypes A–F and subgenotypes B1, B2, C1 and C2. J Clin Virol. 2007;38:238–43.

    Article  CAS  PubMed  Google Scholar 

  18. Tamura K, Dudley J, Nei M, Kumar S. MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0. Mol Biol Evol. 2007;24:1596–9.

    Article  CAS  PubMed  Google Scholar 

  19. Qin Y, Zhang J, Mao R, Guo H, Yin Y, Wu X, et al. Prevalence of basal core promoter and precore mutations in Chinese chronic hepatitis B patients and correlation with serum HBeAG titers. J Med Virol. 2009;81:807–14.

    Article  CAS  PubMed  Google Scholar 

  20. Choi JW, Ahn SH, Park JY, Chang HY, Kim JK, Baatarkhuu O, et al. Hepatitis B e antigen-negative mutations in the precore and core promoter regions in Korean patients. J Med Virol. 2009;81:594–601.

    Article  CAS  PubMed  Google Scholar 

  21. Frelin L, Wahlström T, Tucker AE, Jones J, Hughes J, Lee BO, et al. A mechanism to explain the selection of the hepatitis e antigen-negative mutant during chronic hepatitis B virus infection. J Virol. 2009;83:1379–92.

    Article  CAS  PubMed  Google Scholar 

  22. Chan HL, Wong GL, Tse CH, Chim AM, Yiu KK, Chan HY, et al. Hepatitis B virus genotype C is associated with more severe liver fibrosis than genotype B. Clin Gastroenterol Hepatol. 2009;7:1361–6.

    Article  PubMed  Google Scholar 

  23. Yu MW, Yeh SH, Chen PJ, Liaw YF, Lin CL, Liu CJ, et al. Hepatitis B virus genotype and DNA level and hepatocellular carcinoma: a prospective study in men. J Natl Cancer Inst. 2005;97:265–72.

    Article  CAS  PubMed  Google Scholar 

  24. Yuen MF, Tanaka Y, Fong DY, Fung J, Wong DK, Yuen JC, et al. Independent risk factors and predictive score for the development of hepatocellular carcinoma in chronic hepatitis B. J Hepatol. 2009;50:80–8.

    Article  PubMed  Google Scholar 

  25. Sung JJ, Tsui SK, Tse CH, Ng EY, Leung KS, Lee KH, et al. Genotype-specific genomic markers associated with primary hepatomas, based on complete genomic sequencing of hepatitis B virus. J Virol. 2008;82:3604–11.

    Article  CAS  PubMed  Google Scholar 

  26. Hsieh YH, Su IJ, Wang HC, Chang WW, Lei HY, Lai MD, et al. Pre-S mutant surface antigens in chronic hepatitis B virus infection induce oxidative stress and DNA damage. Carcinogenesis. 2004;25:2023–32.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

We thank the members of our epidemiological teams for their help in field epidemiological study. This work was supported by grants from Ministry of Health of China (2008ZX10002-15), National Natural Science Foundation of China (30921006, 30901272), and Shanghai Science & Technology Committee (08XD14001).

Conflict of interest statement

No conflicts of interest exist.

Author information

Authors and Affiliations

  1. Department of Epidemiology, Second Military Medical University, 800 Xiang-yin Rd., Shanghai, 200433, China

    Jianhua Yin, Jiaxin Xie, Hongwei Zhang, Qiuxia Shen, Lei Han, Wenying Lu, Yifang Han & Guangwen Cao

  2. Department of Infectious Disease, The 1st Affiliated Hospital, Second Military Medical University, Shanghai, China

    Chengzhong Li

  3. Department of Infectious Disease, The 2nd Affiliated Hospital, Second Military Medical University, Shanghai, China

    Wu Ni

  4. Laboratory for Signal Transduction, The 3rd Affiliated Hospital, Second Military Medical University, Shanghai, China

    Hongyang Wang

Authors
  1. Jianhua Yin
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jiaxin Xie
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Hongwei Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Qiuxia Shen
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Lei Han
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Wenying Lu
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Yifang Han
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Chengzhong Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Wu Ni
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Hongyang Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Guangwen Cao
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Guangwen Cao.

Additional information

J. Yin and J. Xie contributed equally to this work.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yin, J., Xie, J., Zhang, H. et al. Significant association of different preS mutations with hepatitis B-related cirrhosis or hepatocellular carcinoma. J Gastroenterol 45, 1063–1071 (2010). https://doi.org/10.1007/s00535-010-0253-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00535-010-0253-1

Keywords

Search

Navigation